Synthesis, characterization and osteoconductivity properties of bone fillers based on alendronate-loaded poly(ε-caprolactone)/hydroxyapatite microspheres

References

Page 1

	Year	Citations
The in vivo degradation, absorption and excretion of PCL-based implant Hongfan Sun, Lin Mei, Cunxian Song, Biomaterials Regenerative MedicineTissue EngineeringImplantable DeviceEngineeringBiomedical Engineering	2005	951
Novel insights into actions of bisphosphonates on bone: Differences in interactions with hydroxyapatite George H. Nancollas, Ruikang Tang, Roger Phipps, Bone Bone DiseaseBone HealthHydroxyapatiteMedicineOsteoarthritis	2005	852
Biodegradable polymers as drug delivery systems Comparative Biochemistry and Physiology Part A Physiology EngineeringResponsive PolymersPolymer ScienceDrug Delivery SystemsBiodegradable Polymers	1992	778
Biodegradable Polymer Scaffolds with Well-Defined Interconnected Spherical Pore Network X. Peter, Jiwon Choi Tissue Engineering	2001	614
Processing and biocompatibility evaluation of laser processed porous titanium Weichang Xue, B. Vamsi Krishna, Amit Bandyopadhyay, Acta Biomaterialia Materials ScienceAdvanced Laser ProcessingEngineeringLaser Processing TechnologyBiomedical Engineering	2007	464
Biodegradable Polymers as Drug Delivery Systems Drug Development and Industrial Pharmacy EngineeringResponsive PolymersPolymer ScienceDrug Delivery SystemsBiodegradable Polymers	1991	434
Coating of VEGF-releasing scaffolds with bioactive glass for angiogenesis and bone regeneration J KENTLEACH, Darnell Kaigler, P Krebsbach, Biomaterials Regenerative MedicineTissue EngineeringVegf-releasing ScaffoldsSynthetic Bone SubstituteEngineering	2006	405
Effects of bisphosphonates on proliferation and osteoblast differentiation of human bone marrow stromal cells Fabian von Knoch, Claude Jaquiéry, Marc S. Kowalsky, Biomaterials Osteoblast DifferentiationBone Morphogenic ProteinOsteoarthritisBone MetabolismMedicine	2005	282
In vitro biocompatibility assessment of poly(ε-caprolactone) films using L929 mouse fibroblasts María Concepción Serrano Biomaterials	2004	271
Inhibition of bone resorption by alendronate and risedronate does not require osteoclast apoptosis Judit Halasy-Nagy, Gideon A. Rodan, A A Reszka Bone Bone ResorptionMedicineOsteoarthritisOsteoporosisPharmacology	2001	189

Page 1